KR880009903A - 폴리아민 유도체 - Google Patents

폴리아민 유도체 Download PDF

Info

Publication number
KR880009903A
KR880009903A KR1019880000970A KR880000970A KR880009903A KR 880009903 A KR880009903 A KR 880009903A KR 1019880000970 A KR1019880000970 A KR 1019880000970A KR 880000970 A KR880000970 A KR 880000970A KR 880009903 A KR880009903 A KR 880009903A
Authority
KR
South Korea
Prior art keywords
compound
bis
formula
propyl
amino
Prior art date
Application number
KR1019880000970A
Other languages
English (en)
Other versions
KR960006551B1 (ko
Inventor
엠.스테메릭크 데이비드
제이.비튼티 알란
엘.에드워즈 마이클
Original Assignee
게리 디.스트리트
메렐 다우 파마슈티칼스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게리 디.스트리트, 메렐 다우 파마슈티칼스 인코포레이티드 filed Critical 게리 디.스트리트
Publication of KR880009903A publication Critical patent/KR880009903A/ko
Application granted granted Critical
Publication of KR960006551B1 publication Critical patent/KR960006551B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/13—Amines containing three or more amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/14—Amines containing amino groups bound to at least two aminoalkyl groups, e.g. diethylenetriamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/23—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton containing carbon-to-carbon triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/57—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
    • C07C211/58—Naphthylamines; N-substituted derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/50—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음.

Description

폴리아민 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (26)

  1. 일반식(Ⅰ)의 화합물 및 약제학적으로 허용되는 이의 염.
    상기식에거, n은 내지 6의 정수이고, m은 3 내지 12의 정수이며, R은 포화 또는 불포화된 C1-6하이드로카빌라디칼 또는 -(CH2)X-(Ar)-X이고, 여기에서 X는 0,1 또는 2이고, Ar은 페닐 또는 나프틸이며, X는 H, C1-6알콕시, 할로겐, C1-4알킬, -S(0)XR(여기서, R1은 C1-6알킬이다)이고, 단 n이 2이고 m이 6또는 10인 경우에는 R은 페닐 메틸인 수는 없다.
  2. 제1항에 있어서, m이 6내지 9의 정수인 화합물.
  3. 제2항에 있어서, n이 3인 화합물.
  4. 제2항에 있어서, R이 벤질인 화합물.
  5. 제2항에 있어서, R이 페닐인 화합물.
  6. 제2항에 있어서, R이 페닐에틸인 화합물.
  7. 제2항에 있어서, 비스-벤질-3-7-3인 화합물.
  8. 제2항에 있어서, 비스-벤질-3-6-3인 화합물.
  9. 제2항에 있어서, 비스-벤질-3-8-3인 화합물.
  10. 제1항의 화합물의 치료적 유효량을 투여함을 특징으로 하여, 원생동물에 의해 유발되는 감염증을 치료하는 방법.
  11. 제10항에 있어서, 오르니틴 데카복실라제 억제제 또는 아르기닌 데카복실라제 억제제와 병용하는 방법.
  12. 제10항에 있어서, 감염증이 플라스모듐(Plasmodium), 트리파노소마(Trupanosoma) 〔살리바리아(Salivaria) 및 스테르코라리아(Stercoraia)포함〕,레이샤마니아(Leishmania), 트리코모나스(Trichomonas), 바베시아(Babesia), 톡소플라슴마(Toxoplasma), 및 테일레리아(Theileria)로 이루어진 속중에서 선택되는 원생동물에 의해 유발되는 방법.
  13. 제12항에 있어서, 오르니틴 데카복실라제 억제제 또는 아르기닌 데카복실라제 억제제와 병용하는 방법.
  14. 제12항에 있어서, 원생동물 감염증에 걸린 숙주가 말라리아에 걸린 숙주인 방법.
  15. 제12항에 있어서, 원생동물 감염증에 걸린 숙주가 샤가(Chaga)질병에 걸린 숙주인 방법.
  16. 제14항에 있어서, 병용치료시 α-디플루오로메틸 오르니틴을 사용하는 방법.
  17. 제15항에 있어서, 병용치료시 α-디플루오로메틸 아르기닌을 사용하는 방법.
  18. 제16항에 있어서, 폴리아민이 N,N′-비스〔3-〔(페닐메틸)아미노〕프로필〕-1,6-헥산디아민인 방법.
  19. 제16항에 있어서, 폴리아민이 N,N′-비스〔3-〔(페닐메틸)아미노〕프로필〕-1,7-헵탄디아민인 방법.
  20. 적절한 N-보호된 테트라민을 일반식(Ⅳ)의 화합물로 반응시킨후, N-말단 알킬화된 생성물을 탈보호시키거나, 일반식(Ⅲ)의 화합물을 일반식(Ⅳ)의 적절한 알데히드로 환원적 알킬화시킨후, 알킬화된 생성물을 N-보호 및 메실화시키고, N-보호 및 메실화된 생성물을 일반식(Ⅴ)의 N-보호된 디아민과 반응시키거나, 부분적으로 N-보호된 테트라민을 아로일 클로라이드로 N-아로일화시킨후 N-아로일화된 생성물을 환원 및 탈보호시키거나, R이 X-(Ar)-(CH2)X(단 X는 0)인 일반식(Ⅰ)의 화합물을 제조하기 위해서 일반식(Ⅵ)의 N-보호된 화합물을 적절한 디할로알칸과 반응시킨후 탈보호시키거나, 또는 R이 불포화된 하이드로카빌 라디칼인 일반식(Ⅰ)의 화합물을 제조하기 위해서는, N-보호된 디아민 메실레이트를 적적한 불포화된 하이드로카빌잔기를 함유하는 N-보호된 아민과 반응시킨후 탈보호시킴을 특징으로하여 일반식(Ⅰ)의 화합물 및 약제학적으로 허용되는 이의 염을 제조하는 방법.
    상기식에서, n은 2내지 6의 정수이고, m은 3내지 12의 정수이며, R은 포화 또는 불포화된 C1-6하이드로카빌라디칼 또는-(CH2)X-(Ar)-X 이고, 여기에서 X는 0,1 또는 2이고, Ar은 페닐 또는 나프틸이며, X는 H,C1-6알콕시, 할로겐, C1-4알킬, 또는-S(0)XR1(여기에서, R1은 C1-6알킬이다.)이고, 단, n이 2이고 m이 6또는 10인 경우에는 R은 페닐메틸일 수는 없으며, R′는 R이 X-(Ar)-(CH2)X인 경우에 X가 0일 수는 없는 것을 제외하고는 R에 대해 정의한 바와 같고, 단 일반식(Ⅳ)에서는 X-(Ar)-(CH2)X(여기에서는 X는 0이 아니다)이며, n′는 0또는 양의 정수이며, Pro는 N-보호그룹이다.
  21. 제20항의 방법으로 제조되는 N,N′-비스〔3-〔(페닐메틸)아미노〕프로필〕-1,7-헵탄디아민.
  22. 제21항에 있어서, N,N′-비스〔3-(아미노)프로필〕-1,7-헵탄디아민을 (브로모메틸)벤젠으로 N-말단 알킬화시키는 방법으로 제조되는 화합물.
  23. 제20항의 방법으로 제조되는 N,N′-비스〔3-〔(페닐메틸)아미노〕프로필〕-1,8-옥탄디아민.
  24. 제23항에 있어서, N,N′-비스〔3-(아미노)프로필〕-1,8-옥탄디아민을 (브로모메틸)벤젠으로 N-말단 알킬화시키는 방법으로 제조되는 화합물.
  25. 제20항의 방법으로 제조되는 N,N′-비스〔3-〔(페닐메틸)아미노〕프로필〕-1,6-헥산디아민.
  26. 제21항에 있어서, N,N′-비스〔3-〔(아미노)-프로필〕-1,6〕-헥산디아민을 (브로모메틸)벤젠으로 N-말단 알킬화시키는 방법으로 제조되는 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880000970A 1987-02-03 1988-02-03 폴리아민 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 KR960006551B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1038087A 1987-02-03 1987-02-03
US010,380 1987-02-03
US010380 1987-02-03

Publications (2)

Publication Number Publication Date
KR880009903A true KR880009903A (ko) 1988-10-05
KR960006551B1 KR960006551B1 (ko) 1996-05-17

Family

ID=21745504

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880000970A KR960006551B1 (ko) 1987-02-03 1988-02-03 폴리아민 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물

Country Status (20)

Country Link
EP (1) EP0277635B1 (ko)
JP (1) JP2556720B2 (ko)
KR (1) KR960006551B1 (ko)
CN (1) CN1021817C (ko)
AR (1) AR246093A1 (ko)
AT (1) ATE99668T1 (ko)
AU (1) AU602186B2 (ko)
CA (1) CA1338764C (ko)
DE (1) DE3886784T2 (ko)
DK (1) DK174418B1 (ko)
ES (1) ES2061528T3 (ko)
FI (1) FI108030B (ko)
HU (2) HU202188B (ko)
IE (1) IE61496B1 (ko)
IL (1) IL85247A (ko)
NO (1) NO166362C (ko)
NZ (1) NZ223340A (ko)
PH (1) PH30970A (ko)
PT (1) PT86687B (ko)
ZA (1) ZA88600B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109024A (en) * 1987-02-03 1992-04-28 Merrell Dow Pharmaceuticals Inc. Polyamine derivatives as antineoplastic agents
US5753714A (en) * 1987-02-03 1998-05-19 Merrell Pharmaceuticals Inc. Polyamine derivatives
ZA887410B (en) * 1987-10-08 1989-06-28 Merrell Dow Pharma Polyamine derivatives as antineoplastic agents
US4935449A (en) * 1988-08-04 1990-06-19 Merrell Dow Pharmaceuticals Inc. N-2,3-butadienyl tri- and tetraaminoalkane derivatives
EP0378146B1 (en) * 1989-01-10 1995-03-29 Merrell Pharmaceuticals Inc. Polyamine derivatives as antineoplastic agents
ZA903804B (en) * 1989-05-23 1991-03-27 Merrell Dow Pharma A method of potentiating cell-mediated immunity utilizing polyamine derivatives
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
ZA919695B (en) * 1990-12-13 1992-09-30 Merrell Dow Pharma Method of treating cancer by conjunctive therapy with n,n'-bis(3-(ethylamino)propyl)-1,7-heptanediamine and a cytotoxic agent
US5561136A (en) * 1990-12-13 1996-10-01 Merrell Pharmaceuticals Inc. Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
US5354782A (en) * 1991-01-17 1994-10-11 Merrell Dow Pharmaceuticals Inc. Polyamine phenols as radioprotective agents
US5217964A (en) * 1991-01-23 1993-06-08 Merrell Dow Pharmaceuticals Inc. Polyamine thiols as radioprotective agents
KR100311851B1 (ko) * 1993-02-23 2002-04-24 슈테펜엘.네스비트 방사선보호제로서의폴리아민유도체
CA2155095A1 (en) * 1993-12-27 1995-07-06 Jorg Frei Unsaturate amino compounds for use as anticancer and antiprotozoic agent
US5516807A (en) * 1994-10-25 1996-05-14 Warner-Lambert Company Method for treating vascular proliferative disorders following balloon angioplasty
AU703340B2 (en) * 1995-06-26 1999-03-25 Chelator Llc Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
FR2749845B1 (fr) * 1996-06-18 1998-08-21 Oreal Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques
US7087648B1 (en) 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
WO2003013245A1 (en) 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
BRPI0614805A2 (pt) * 2005-08-10 2011-04-12 Univ Johns Hopkins poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
EP2190404A1 (en) * 2007-09-18 2010-06-02 Fujifilm Manufacturing Europe B.V. Uv absorbing compounds
CN102753604B (zh) * 2010-01-04 2015-01-21 罗地亚经营管理公司 多胺及其制造方法
CN103242256A (zh) * 2013-05-21 2013-08-14 苏州科捷生物医药有限公司 一种3-胺甲基-异噁唑盐酸盐的合成方法
CN111989316B (zh) * 2018-01-30 2023-09-08 潘贝拉治疗股份有限公司 用于生产(6s,15s)-3,8,13,18-四氮杂二十烷-6,15-二醇的方法
CN112218849B (zh) * 2018-04-06 2023-08-18 巴斯夫欧洲公司 用于制备胺的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013020A (en) * 1958-01-24 1961-12-12 Miles Lab N,n'-bis-phenyl-alkylene-diamines
DE2458222A1 (de) * 1973-12-19 1975-07-03 Sandoz Ag Verfahren zur herstellung neuer phenylaethylaminderivate
DE2557657A1 (de) * 1975-12-20 1977-06-30 Knoll Ag Neue spermin-derivate
DE2938710A1 (de) * 1979-09-25 1981-04-09 Hoechst Ag, 6000 Frankfurt N,n'-dialkylaminoalkylethylendiamine und verfahren zu deren herstellung
NZ212053A (en) * 1984-05-17 1988-02-29 Merrell Dow Pharma Polyamine containing pharmaceutical compositions for treating neoplasms
GB8419103D0 (en) * 1984-07-26 1984-08-30 Beecham Wuelfing Gmbh & Co Kg Compounds
ZA887410B (en) * 1987-10-08 1989-06-28 Merrell Dow Pharma Polyamine derivatives as antineoplastic agents

Also Published As

Publication number Publication date
NO166362B (no) 1991-04-02
NO880452D0 (no) 1988-02-02
JPS63222149A (ja) 1988-09-16
NO880452L (no) 1988-08-04
HU202188B (en) 1991-02-28
IL85247A0 (en) 1988-07-31
NO166362C (no) 1991-07-10
AU1090288A (en) 1988-08-11
CN88100500A (zh) 1988-09-07
HUT50315A (en) 1990-01-29
PT86687A (pt) 1988-03-01
DK52388D0 (da) 1988-02-02
FI880469A (fi) 1988-08-04
DK52388A (da) 1988-08-04
IE880285L (en) 1988-08-03
EP0277635A2 (en) 1988-08-10
AR246093A1 (es) 1994-03-30
FI880469A0 (fi) 1988-02-02
CN1021817C (zh) 1993-08-18
FI108030B (fi) 2001-11-15
NZ223340A (en) 1991-03-26
DE3886784D1 (de) 1994-02-17
EP0277635B1 (en) 1994-01-05
PH30970A (en) 1997-12-23
EP0277635A3 (en) 1989-07-19
ZA88600B (en) 1988-07-28
IE61496B1 (en) 1994-11-02
ATE99668T1 (de) 1994-01-15
IL85247A (en) 1992-03-29
DE3886784T2 (de) 1994-05-05
HU210205A9 (en) 1995-02-28
AU602186B2 (en) 1990-10-04
PT86687B (pt) 1992-04-30
CA1338764C (en) 1996-12-03
JP2556720B2 (ja) 1996-11-20
DK174418B1 (da) 2003-02-17
KR960006551B1 (ko) 1996-05-17
ES2061528T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
KR880009903A (ko) 폴리아민 유도체
DE69532760D1 (de) Mittel zur verabreichung von antigenen
ATE219358T1 (de) Sublinguale und bukkale verabreichung von selegilin
DE69030100D1 (de) Peptidderivat, verfahren zu dessen herstellung, sowie dieses enthaltende pharmazeutische zusammensetzung
EP0203676A3 (en) Vaccine for generating an immunogenic t cell response protective against a virus
DE69006072D1 (de) Verfahren zur Herstellung von N-Methyl-3-(p-Trifluoromethyl-phenoxy)-3-phenyl-propylamin und ihre Salze.
KR960022542A (ko) 광학 활성 벤조티에핀 유도체, 그의 제조방법 및 용도
EP0214557A3 (en) Use of serotonin antagonists, particularly cyproheptadine, in the treatment of cancer, alzheimer's disease, aids and multiple sclerosis
DE3888778D1 (de) Polyamin-Derivate als antineoplastische Wirkstoffe.
SU1706390A3 (ru) Способ получени гидрохлорида N- @ (4-[(индоло-(3,2-в)хинолин-10-ил)амино]-3-метоксифенил @ )-метансульфонамида
DE69028006D1 (de) Verwendung von Polyaminderivaten zur Verstärkung der zellularen Immunität
KR860001083A (ko) 신규의 모르포리놀의 제법
PT92952A (pt) Processo para a preparacao de acidos 3-fenil-5,6-di-hidrobenz { c }acridina-7- carboxilicos, de compostos relacionados e de composicoes farmaceuticas que os contem
KR900014309A (ko) 신규 기관지진경제 및 그의 제조방법
HUT39150A (en) Process for preparing immunologically active compounds
KR880011098A (ko) 4-페닐피페리딘 화합물, 이의 제조방법 및 용도
KR890012961A (ko) N-(저급알킬)-2-(3'-우레이도벤질)피롤리딘
GR3001147T3 (en) N-((trimethoxy-2,4,6-benzoyl)-3 propyl)piperidine derivatives, process for their preparation and their therapeutical use
KR910011258A (ko) 녹내장의 치료방법
KR890003725A (ko) 아민유도체 및 이의 염, 이의 제조방법 및 이를 함유하는 궤양치료제
ATE295728T1 (de) Herstellung von 3-fluoroxindolderivaten
KR910018342A (ko) 하이드록실아민 화합물
MY106222A (en) Azole-1-alkanamides as antiarrhythmic agents and preparation thereof.
KR840002374A (ko) 디옥산 진통제의 합성방법
KR870007200A (ko) 펩티딜 아미노디올의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040510

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee